Genetic Polymorphism and Natural Selection of Circumsporozoite Surface Protein in Plasmodium Falciparum Field Isolates from Myanmar

Overview

Journal Malar J

Publisher Biomed Central

Specialty Tropical Medicine

Date 2018 Oct 14

PMID 30314440

Citations 17

Authors

Huong Giang Le

Jung-Mi Kang

Mya Moe

Hojong Jun

Th Lam Thai

Jinyoung Lee

Moe Kyaw Myint

Khin Lin

Woon-Mok Sohn

Ho-Joon Shin

Tong-Soo Kim

Byoung-Kuk Na

Affiliations

Soon will be listed here.

Abstract

Background: Plasmodium falciparum circumsporozoite protein (PfCSP) is one of the most extensively studied malaria vaccine candidates, but the genetic polymorphism of PfCSP within and among the global P. falciparum population raises concerns regarding the efficacy of a PfCSP-based vaccine efficacy. In this study, genetic diversity and natural selection of PfCSP in Myanmar as well as global P. falciparum were comprehensively analysed.

Methods: Blood samples were collected from 51 P. falciparum infected Myanmar patients. Fifty-one full-length PfCSP genes were amplified from the blood samples through a nested polymerase chain reaction, cloned into a TA cloning vector, and then sequenced. Polymorphic characteristics and natural selection of Myanmar PfCSP were analysed using the DNASTAR, MEGA6, and DnaSP programs. Polymorphic diversity and natural selection in publicly available global PfCSP were also analysed.

Results: The N-terminal and C-terminal non-repeat regions of Myanmar PfCSP showed limited genetic variations. A comparative analysis of the two regions in global PfCSP displayed similar patterns of low genetic diversity in global population, but substantial geographic differentiation was also observed. The most notable polymorphisms identified in the N-terminal region of global PfCSP were A98G and 19-amino acid length insertion in global population with different frequencies. Major polymorphic characters in the C-terminal region of Myanmar and global PfCSP were found in the Th2R and Th3R regions, where natural selection and recombination occurred. The central repeat region of Myanmar PfCSP was highly polymorphic, with differing numbers of repetitive repeat sequences NANP and NVDP. The numbers of the NANP repeats varied among global PfCSP, with the highest number of repeats seen in Asian and Oceanian PfCSP. Haplotype network analysis of global PfCSP revealed that global PfCSP clustered into 103 different haplotypes with geographically-separated populations.

Conclusion: Myanmar and global PfCSP displayed genetic diversity. N-terminal and C-terminal non-repeat regions were relatively conserved, but the central repeat region displayed high levels of genetic polymorphism in Myanmar and global PfCSP. The observed geographic pattern of genetic differentiation and the points of evidence for natural selection and recombination suggest that the functional consequences of the polymorphism should be considered for developing a vaccine based on PfCSP.

Citing Articles

Genetic diversity of Plasmodium falciparum reticulocyte binding protein homologue-5, which is a potential malaria vaccine candidate: baseline data from areas of varying malaria endemicity in Mainland Tanzania.

Kisambale A, Pereus D, Mandai S, Lyimo B, Bakari C, Chacha G Malar J. 2025; 24(1):29.

PMID: 39871346 PMC: 11773767. DOI: 10.1186/s12936-025-05269-x.

Genetic variation of the circumsporozoite protein in parasite isolates from Homabay County in Kenya.

Maina M, Musundi S, Kuja J, Waweru H, Kiboi D, Kanoi B Front Parasitol. 2025; 3():1346017.

PMID: 39817167 PMC: 11732096. DOI: 10.3389/fpara.2024.1346017.

Estimation of PfRh5-based vaccine efficacy in asymptomatic patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening.

Jun H, Mazigo E, Lee W, Louis J, Syahada J, Fitriana F Front Immunol. 2024; 15:1495513.

PMID: 39624090 PMC: 11609159. DOI: 10.3389/fimmu.2024.1495513.

Genetic polymorphism and evidence of signatures of selection in the Plasmodium falciparum circumsporozoite protein gene in Tanzanian regions with different malaria endemicity.

Lyimo B, Bakari C, Popkin-Hall Z, Giesbrecht D, Seth M, Pereus D Malar J. 2024; 23(1):139.

PMID: 38720288 PMC: 11080125. DOI: 10.1186/s12936-024-04974-3.

Genetic polymorphism and evidence of signatures of selection in the circumsporozoite protein gene in Tanzanian regions with different malaria endemicity.

Lyimo B, Bakari C, Popkin-Hall Z, Giesbrecht D, Seth M, Pereus D medRxiv. 2024; .

PMID: 38343796 PMC: 10854334. DOI: 10.1101/2024.01.23.24301587.

References

Tajima F . Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989; 123(3):585-95. PMC: 1203831. DOI: 10.1093/genetics/123.3.585. View

Agnandji S, Lell B, Fernandes J, Abossolo B, Methogo B, Lumeka Kabwende A . A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med. 2012; 367(24):2284-95. PMC: 10915853. DOI: 10.1056/NEJMoa1208394. View

Zakeri S, Avazalipoor M, Mehrizi A, Djadid N, Snounou G . Restricted T-cell epitope diversity in the circumsporozoite protein from Plasmodium falciparum populations prevalent in Iran. Am J Trop Med Hyg. 2007; 76(6):1046-51. View

Kumkhaek C, Phra-Ek K, Renia L, Singhasivanon P, Looareesuwan S, Hirunpetcharat C . Are extensive T cell epitope polymorphisms in the Plasmodium falciparum circumsporozoite antigen, a leading sporozoite vaccine candidate, selected by immune pressure?. J Immunol. 2005; 175(6):3935-9. DOI: 10.4049/jimmunol.175.6.3935. View

Fu Y, Li W . Statistical tests of neutrality of mutations. Genetics. 1993; 133(3):693-709. PMC: 1205353. DOI: 10.1093/genetics/133.3.693. View

Rathore D, Sacci J, De La Vega P, McCutchan T . Binding and invasion of liver cells by Plasmodium falciparum sporozoites. Essential involvement of the amino terminus of circumsporozoite protein. J Biol Chem. 2001; 277(9):7092-8. DOI: 10.1074/jbc.M106862200. View

. Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites. PLoS Med. 2014; 11(7):e1001685. PMC: 4114488. DOI: 10.1371/journal.pmed.1001685. View

Agnandji S, Lell B, Soulanoudjingar S, Fernandes J, Abossolo B, Conzelmann C . First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med. 2011; 365(20):1863-75. DOI: 10.1056/NEJMoa1102287. View

Sidjanski S, Vanderberg J, Sinnis P . Anopheles stephensi salivary glands bear receptors for region I of the circumsporozoite protein of Plasmodium falciparum. Mol Biochem Parasitol. 1998; 90(1):33-41. PMC: 4011076. DOI: 10.1016/s0166-6851(97)00124-2. View

10.

Friedman J, Esko J, Sinnis P . The binding of the circumsporozoite protein to cell surface heparan sulfate proteoglycans is required for plasmodium sporozoite attachment to target cells. J Biol Chem. 2001; 276(29):26784-91. PMC: 3941197. DOI: 10.1074/jbc.M104038200. View

11.

Ferguson D, Balaban A, Patzewitz E, Wall R, Hopp C, Poulin B . The repeat region of the circumsporozoite protein is critical for sporozoite formation and maturation in Plasmodium. PLoS One. 2014; 9(12):e113923. PMC: 4250072. DOI: 10.1371/journal.pone.0113923. View

12.

Kang J, Cho P, Moe M, Lee J, Jun H, Lee H . Comparison of the diagnostic performance of microscopic examination with nested polymerase chain reaction for optimum malaria diagnosis in Upper Myanmar. Malar J. 2017; 16(1):119. PMC: 5356273. DOI: 10.1186/s12936-017-1765-4. View

13.

Coppi A, Natarajan R, Pradel G, Bennett B, James E, Roggero M . The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian host. J Exp Med. 2011; 208(2):341-56. PMC: 3039851. DOI: 10.1084/jem.20101488. View

14.

Putaporntip C, Jongwutiwes S, Hughes A . Natural selection maintains a stable polymorphism at the circumsporozoite protein locus of Plasmodium falciparum in a low endemic area. Infect Genet Evol. 2009; 9(4):567-73. PMC: 4009382. DOI: 10.1016/j.meegid.2009.02.006. View

15.

Waitumbi J, Anyona S, Hunja C, Kifude C, Polhemus M, Walsh D . Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial. PLoS One. 2009; 4(11):e7849. PMC: 2773849. DOI: 10.1371/journal.pone.0007849. View

16.

Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G . Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature. 2012; 487(7407):375-9. PMC: 3738909. DOI: 10.1038/nature11174. View

17.

Escalante A, Grebert H, Isea R, Goldman I, Basco L, Magris M . A study of genetic diversity in the gene encoding the circumsporozoite protein (CSP) of Plasmodium falciparum from different transmission areas--XVI. Asembo Bay Cohort Project. Mol Biochem Parasitol. 2002; 125(1-2):83-90. DOI: 10.1016/s0166-6851(02)00216-5. View

18.

Bongfen S, Ntsama P, Offner S, Smith T, Felger I, Tanner M . The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity. Vaccine. 2008; 27(2):328-35. DOI: 10.1016/j.vaccine.2008.09.097. View

19.

Tamura K, Stecher G, Peterson D, Filipski A, Kumar S . MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013; 30(12):2725-9. PMC: 3840312. DOI: 10.1093/molbev/mst197. View

20.

Tan J, Sack B, Oyen D, Zenklusen I, Piccoli L, Barbieri S . A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein. Nat Med. 2018; 24(4):401-407. PMC: 5893353. DOI: 10.1038/nm.4513. View